Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 651

    1.

    Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.

    Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA Jr, Korducki L, Cassino C, Kesten S.

    Ann Intern Med. 2005 Sep 6;143(5):317-26.PMID: 16144890 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

    Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

    Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.PMID: 17310045 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

    Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr.

    Eur Respir J. 2002 Feb;19(2):217-24.PMID: 11866001 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

    Keam SJ, Keating GM.

    Treat Respir Med. 2004;3(4):247-68. Review.PMID: 15350163 [PubMed - indexed for MEDLINE]Related articles

    5.

    Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.

    Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S.

    Thorax. 2003 May;58(5):399-404. Erratum in: Thorax. 2005 Feb;60(2):105. PMID: 12728159 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

    Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators.

    Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26. Epub 2007 Oct 4.PMID: 17916806 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).

    Friedman M, Menjoge SS, Anton SF, Kesten S.

    Pharmacoeconomics. 2004;22(11):741-9.PMID: 15250751 [PubMed - indexed for MEDLINE]Related articles

    8.

    A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

    Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

    N Engl J Med. 2008 Oct 9;359(15):1543-54. Epub 2008 Oct 5.PMID: 18836213 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

    Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S.

    Chest. 2005 Mar;127(3):809-17.PMID: 15764761 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Inhaled tiotropium for stable chronic obstructive pulmonary disease.

    Barr RG, Bourbeau J, Camargo CA, Ram FS.

    Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002876. Review.PMID: 15846642 [PubMed - indexed for MEDLINE]Related articles

    11.

    Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.

    Hodder R, Kesten S, Menjoge S, Viel K.

    Int J Chron Obstruct Pulmon Dis. 2007;2(2):157-67.PMID: 18044688 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease.

    Criner GJ, Sharafkhaneh A, Player R, Conoscenti CS, Johnson P, Keyser MT, Cassino C.

    COPD. 2008 Feb;5(1):35-41.PMID: 18259973 [PubMed - indexed for MEDLINE]Related articles

    13.

    Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.

    Ambrosino N, Foglio K, Balzano G, Paggiaro PL, Lessi P, Kesten S; Tiotropium Multicentric Italian Study Group.

    Int J Chron Obstruct Pulmon Dis. 2008;3(4):771-80.PMID: 19281092 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    [Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease]

    Baloira Villar A, Vilariño Pombo C.

    Arch Bronconeumol. 2005 Mar;41(3):130-4. Spanish. PMID: 15766465 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The Canadian Optimal Therapy of COPD Trial: design, organization and patient recruitment.

    Aaron SD, Vandemheen K, Fergusson D, Fitzgerald M, Maltais F, Bourbeau J, Goldstein R, McIvor A, Balter M, O'donnell D.

    Can Respir J. 2004 Nov-Dec;11(8):581-5.PMID: 15611808 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan.

    Hsu JY, Perng RP, Lu JY, Wu CP, Huang MS, Luh KT, Yang PC.

    J Formos Med Assoc. 2006 Sep;105(9):708-14.PMID: 16959618 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.

    Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ Jr, Kesten S, Towse L.

    Chest. 2002 Jul;122(1):47-55.PMID: 12114338 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

    Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L, Cornelissen PJ; Dutch/Belgian Tiotropium Study Group.

    Eur Respir J. 2002 Feb;19(2):209-16.PMID: 11871363 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.

    ZuWallack AR, ZuWallack RL.

    Expert Opin Pharmacother. 2004 Aug;5(8):1827-35. Review. Erratum in: Expert Opin Pharmacother. 2004 Sep;5(9):2051. PMID: 15264997 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.

    Calverley PM, Lee A, Towse L, van Noord J, Witek TJ, Kelsen S.

    Thorax. 2003 Oct;58(10):855-60.PMID: 14514937 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data